JP Stock MarketDetailed Quotes
4575 CanBas
- 461
- -4-0.86%
20min DelayMarket Closed May 2 15:00 JST
8.31BMarket Cap-5552P/E (Static)
476High455Low206.60KVolume460Open465Pre Close95.73MTurnover166652wk High1.22%Turnover Ratio18.02MShares41152wk Low-65.28EPS TTM7.79BFloat Cap4530Historical HighLossP/E (Static)16.90MShs Float162Historical Low-83.03EPS LYR4.52%Amplitude--Dividend TTM2.64P/B100Lot Size--Div YieldTTM
About CanBas Company
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
Company Profile
Symbol4575
Company NameCanBas
Founded2000-01-18
MarketTSE Growth
Fiscal Year Ends06-30
Address9 Toriyoko-cho
Zip Code410-0801
Phone055-954-3666
Websitewww.canbas.co.jp
Company Executives
- Name
- Position
- Salary
- Makoto Katozumi
- Director, Chief Financial Officer and Head of Corporate Planning Office
- --
- Toshiyuki Hibino
- Director, Chief Operating Officer and Head of Research and Development
- --
- Takumi Kawabe
- President and Representative Director
- --
- Kazuyoshi Sakamoto
- Director and Head of Administration
- --
- Toshio Furuta
- Independent Director
- --
- Akira Shirakawa
- Independent Director
- --
- Yasuyuki Komiyama
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg